EcoDrugPlus

Ensembl ID : ENSMMDG00005005057
Gene Symbol: -
Cross references: -
203 Possible Orthologues:

Ensembl ID : ENSMMDG00005013898
Gene Symbol: -
Cross references: -
190 Possible Orthologues:

Ensembl ID : ENSMMDG00005013899
Gene Symbol: -
Cross references: -
190 Possible Orthologues:

Ensembl ID : ENSMMDG00005014666
Gene Symbol: SLC22A6L
1 Cross references
357 Possible Orthologues:

Ensembl ID : ENSMMDG00005014873
Gene Symbol: -
Cross references: -
192 Possible Orthologues:

Ensembl ID : ENSMMDG00005014926
Gene Symbol: SLC22A6L
1 Cross references
357 Possible Orthologues:

Ensembl ID : ENSMMDG00005021882
Gene Symbol: -
Cross references: -
486 Possible Orthologues:

Ensembl ID : ENSMMDG00005022443
Gene Symbol: VEGFAA
1 Cross references
181 Possible Orthologues:

Ensembl ID : ENSMMDG00005004034
Gene Symbol: -
Cross references: -
226 Possible Orthologues:

Ensembl ID : ENSMMDG00005015504
Gene Symbol: RPL34
1 Cross references
362 Possible Orthologues:

Ensembl ID : ENSMMDG00005015492
Gene Symbol: -
Cross references: -
161 Possible Orthologues:

Ensembl ID : ENSMMDG00005002386
Gene Symbol: -
Cross references: -
191 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).